ViroStatics is committed to expand its know how and expertise. In many cases this will include establishing mutually beneficial partnerships with organizations that have complementary strengths. Current collaborations include:
DIVISION OF MICROBIOLOGY AND INFECTIOUS DISEASES
Supports extramural research to control and prevent diseases caused by virtually all human infectious agents
Drug development partner, worked for Genentech, Pfizer, Bayer. Several compounds advanced to Phase 2 & 3
Promote research and technology transfer and the development of a knowledge-based local economy
Active in complementary areas of technology: biomarker discovery, diagnostic systems and biotechnologies in nutrition and health
